However, there are data to support high tumor VEGF-C expression as a negative prognostic factor, independent of other variables, in non-small cell lung cancer [44], esophageal cancer [45], and gastric cancer [46], while high plasma levels of VEGF-C served as an independent negative prognostic factor in colorectal cancer [47]. This evidence concerns the gene VEGFC and esophageal cancer.